| 名稱 | CYP2D6*10 Reference Standard |
| 型號(hào) | CBPA0072 |
| 報(bào)價(jià) |  |
| 特點(diǎn) | CYP2D6*10 Reference Standard |
產(chǎn)品搜索
相關(guān)文章
- CYP2C9基因多態(tài)性用藥指導(dǎo)標(biāo)準(zhǔn)品
- CYP1A1基因多態(tài)性用藥指導(dǎo)標(biāo)準(zhǔn)品
- VKORC1基因多態(tài)性用藥指導(dǎo)標(biāo)準(zhǔn)品
- MTHFR基因多態(tài)性用藥指導(dǎo)標(biāo)準(zhǔn)品
- CYP2D6基因多態(tài)性用藥指導(dǎo)標(biāo)準(zhǔn)品
- CYP2C19基因多態(tài)性用藥指導(dǎo)標(biāo)準(zhǔn)品
- BCR-ABL激酶抑制劑細(xì)胞篩選模型
- Nectin-4, ADC賽道新星靶點(diǎn)
- 羅氏乳腺癌新藥獲英國(guó)NICE批準(zhǔn)用于HER2乳腺癌新輔助治療
- Canine IL-31細(xì)胞篩選模型
聯(lián)系我們
聯(lián)系人：蔣經(jīng)理
電話：4008750250
號(hào)碼：
手機(jī)：18066071954
地址：南京市棲霞區(qū)緯地路9號(hào)
Email： zhangxiangwen@cobioer.com
電話：4008750250
號(hào)碼：
手機(jī)：18066071954
地址：南京市棲霞區(qū)緯地路9號(hào)
Email： zhangxiangwen@cobioer.com
產(chǎn)品展示 / PRODUCTS
基因檢測(cè)標(biāo)準(zhǔn)品 > 用藥指導(dǎo) > CBPA0072CYP2D6*10 Reference Standard
- 詳細(xì)內(nèi)容
| CBPA0072 | |
| Format | Genomic DNA |
| Description | CYP2D6, cytochrome P450 family 2 subfamily D member 6, is a member of the cytochrome P450 family of monooxygenases that catalyzes drug metabolism (PMID: 28480783). CYP2D6 variants have been associated with risks of various cancers (PMID: 22994728, PMID: 16550168) and may alter the metabolism of tamoxifen in breast cancer patients. |
| Technical Data | |
| Gene | CYP2D6 |
| Mutation Type 1 | AA Change: p.S486T |
| DNA Change: NM_000106.6:c.1457G>C | |
| Chr position (GRCh38): chr22:42126611 | |
| Mutation Type 2 | AA Change: p.P34S |
| DNA Change: NM_000106.6:c.100C>T | |
| Chr position (GRCh38): chr22:42130692 | |
| Allelic Frequency | 100% |
| Zygosity | Homozygous |
| Product Information | |
| Intended Use | Research Use Only |
| Unit Size | 1ug |
| Concentration | Download for COA |
| Purofication | Download for COA |
| DNA electrophoresis | Download for COA |
| Sanger sequencing | Figure 1. CYP2D6*10 Reference Standard p.S486T
Figure 2. CYP2D6*10 Reference Standard p.P34S |
| Storage | 4°C |
| Expiry | 36 months from the date of manufacture |
會(huì)員_a.png)